Welcome to our dedicated page for Comerica SEC filings (Ticker: CMA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Comerica Incorporated (NYSE: CMA) provides direct access to the company’s official regulatory disclosures as a publicly traded financial services and commercial banking institution. These documents are a primary source for understanding Comerica’s corporate actions, capital structure, and its pending all-stock merger with Fifth Third Bancorp.
Investors will find current reports on Form 8-K that describe key events, including entry into the Agreement and Plan of Merger with Fifth Third, subsequent joint press releases, and updates on regulatory and shareholder approvals. For example, Comerica’s 8-K filings outline the structure of the merger, the planned sequence of corporate and bank mergers, the exchange ratio for Comerica common stock, and the conditions required for closing. Other 8-Ks report quarterly earnings releases, dividend declarations on common and Series B preferred stock, and the issuance of Series B preferred depositary shares.
Filings also detail capital and securities information, such as the Certificate of Designations for the 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B, and the related deposit agreement for the associated depositary shares. These documents explain dividend rights, voting powers, redemption terms and restrictions that apply to common stock dividends and repurchases when preferred dividends are not declared and paid or set aside.
Merger-related filings describe the regulatory approval process and legal framework governing the transaction with Fifth Third. They discuss required approvals from the Federal Reserve, the Office of the Comptroller of the Currency and other regulators, as well as shareholder votes, termination fee provisions and litigation or stockholder demands concerning proxy disclosures. Question-and-answer sections in supplemental proxy-related 8-Ks further explain what happens if the merger is not completed or if stockholders vote against the transaction.
On Stock Titan, these SEC filings are updated in near real time as they are posted to EDGAR. AI-powered summaries can help interpret lengthy documents such as merger agreements, proxy materials, and capital-related filings, highlighting key terms, conditions, and risk factors. Users can quickly identify items related to quarterly results (10-Q), annual reporting (10-K, when referenced), current events (8-K), and securities offerings or preferred stock designations, and use the structured data to analyze how the Comerica–Fifth Third combination and other corporate actions may affect CMA shareholders and preferred holders.
Comerica Incorporated issued and sold 16,000,000 depositary shares, each representing a 1/40th interest in a share of its 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B. The Series B carries a stated dividend rate of 6.875% and a liquidation preference of $1,000 per preferred share (equivalent to $25 per depositary share). The offering generated approximately $392.2 million in net proceeds after underwriting discounts and estimated offering expenses.
The company filed a Certificate of Designations amending its charter to establish the Series B rights, and issued the depositary shares pursuant to a Deposit Agreement with Computershare. Holders of the depositary shares are entitled to proportional dividend, voting, redemption and liquidation rights. The Series B includes provisions that restrict the company’s ability to pay dividends on, distribute or repurchase common stock if dividends on the Series B were not declared and either paid or set aside for the immediately preceding dividend period.
Comerica Incorporated submitted a Form 144 reporting a proposed sale of 2,100 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $140,773.50. The filing lists the approximate date of sale as 08/08/2025 and names the NYSE as the exchange, and reports total shares outstanding of 128,525,470.
The notice includes the acquisition history for the shares, showing multiple lots acquired between 03/31/2023 and 06/30/2025 via ESPP purchases and restricted stock vesting (notable vesting amounts include 854 and 524 shares). The provided content does not include the filer’s identifying CIK or filer name in the visible fields.
Comerica Incorporated reports a proposed insider sale of 4,000 common shares through Fidelity Brokerage Services LLC on the NYSE with an approximate sale date of 08/08/2025. The filing lists an aggregate market value of $269,140 and shows 128,525,470 shares outstanding, indicating the sale represents a very small fraction of total equity.
The shares were acquired as restricted stock vesting on 01/26/2023 (1,274 shares) and 02/28/2023 (2,726 shares) and were paid as compensation. The filer reports "Nothing to Report" for securities sold in the past three months and affirms no undisclosed material adverse information.